GKOS Latest Press Releases

-- April 16, 2026 --

Glaukos Announces the Release of its 2025 Sustainability Report Business Wire 7:00 AM

-- April 15, 2026 --

Glaukos Receives Permanent J-code for Epioxa Business Wire 4:05 PM

-- April 8, 2026 --

Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29 Business Wire 7:00 AM

-- April 6, 2026 --

Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting Business Wire 7:00 AM

-- March 19, 2026 --

Glaukos Announces Commercial Availability of Epioxa , a Transformative Innovation in Interventional Keratoconus Care Business Wire 7:00 AM

-- February 17, 2026 --

Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results Business Wire 4:05 PM

-- January 28, 2026 --

Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose TR Business Wire 7:00 AM

-- January 20, 2026 --

Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17 Business Wire 7:00 AM

-- January 13, 2026 --

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance Business Wire 4:05 PM

-- December 16, 2025 --

Glaukos Announces Participation in J.P. Morgan Healthcare Conference Business Wire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software